Enveric Biosciences, Inc. (ENVB)

Verve Therapeutics Statistics

Total Valuation

ENVB has a market cap or net worth of $2.84 million. The enterprise value is -$1.45 million.

Market Cap	2.84M
Enterprise Value	-1.45M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

ENVB has 2.47 million shares outstanding. The number of shares has increased by 403.24% in one year.

Current Share Class	2.47M
Shares Outstanding	2.47M
Shares Change (YoY)	+403.24%
Shares Change (QoQ)	+173.48%
Owned by Insiders (%)	0.98%
Owned by Institutions (%)	11.62%
Float	2.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.73
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.08

Current Ratio	4.08
Quick Ratio	3.63
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-19,668.38

Financial Efficiency

Return on equity (ROE) is -178.91% and return on invested capital (ROIC) is -112.29%.

Return on Equity (ROE)	-178.91%
Return on Assets (ROA)	-83.70%
Return on Invested Capital (ROIC)	-112.29%
Return on Capital Employed (ROCE)	-238.47%
Revenue Per Employee	n/a
Profits Per Employee	-$1.55M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ENVB has paid $7,199 in taxes.

Income Tax	7,199
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.69% in the last 52 weeks. The beta is 0.37, so ENVB's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-86.69%
50-Day Moving Average	1.26
200-Day Moving Average	2.97
Relative Strength Index (RSI)	38.56
Average Volume (20 Days)	189,052

Short Selling Information

The latest short interest is 213,496, so 8.64% of the outstanding shares have been sold short.

Short Interest	213,496
Short Previous Month	269,004
Short % of Shares Out	8.64%
Short % of Float	8.72%
Short Ratio (days to cover)	1.38

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.34M
Pretax Income	-15.04M
Net Income	-9.30M
EBITDA	-9.01M
EBIT	-9.34M
Earnings Per Share (EPS)	-$10.50

Balance Sheet

The company has $4.29 million in cash and n/a in debt, giving a net cash position of $4.29 million or $1.74 per share.

Cash & Cash Equivalents	4.29M
Total Debt	n/a
Net Cash	4.29M
Net Cash Per Share	$1.74
Equity (Book Value)	3.92M
Book Value Per Share	1.59
Working Capital	3.65M

Cash Flow

Operating Cash Flow	-7.52M
Capital Expenditures	n/a
Free Cash Flow	-7.52M
FCF Per Share	-$3.04

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ENVB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-403.24%
Shareholder Yield	-403.24%
Earnings Yield	-327.29%
FCF Yield	-264.54%

Analyst Forecast

The average price target for ENVB is $10.00, which is 769.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	769.57%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 29, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Jan 29, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	2